OPRM1 and bone cancer: For example, among DEGs in early stage, Oprm1 was opioid receptor [25], the reduced expression of which in dorsal root ganglion neurons was found to be associated with bone cancer pain in mouse models [26]. Tmem200a was a transmembrane protein which might inhibit overgrowth of myelocyte [27].